| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT10 KRT77 KRT76 | 1.40e-26 | 43 | 17 | 11 | GO:0030280 |
| GeneOntologyMolecularFunction | structural molecule activity | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.54e-21 | 891 | 17 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 6.01e-14 | 130 | 17 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.79e-03 | 93 | 17 | 2 | GO:0097110 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 2.84e-39 | 75 | 17 | 16 | GO:0045109 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.75e-37 | 99 | 17 | 16 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 4.47e-37 | 100 | 17 | 16 | GO:0045103 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT10 KRT77 KRT14 KRT76 KRT16 | 4.87e-24 | 189 | 17 | 13 | GO:0030216 |
| GeneOntologyBiologicalProcess | epidermis development | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 1.81e-23 | 461 | 17 | 15 | GO:0008544 |
| GeneOntologyBiologicalProcess | keratinization | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT77 KRT76 KRT16 | 4.73e-23 | 87 | 17 | 11 | GO:0031424 |
| GeneOntologyBiologicalProcess | skin development | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT76 KRT16 | 2.03e-22 | 373 | 17 | 14 | GO:0043588 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT10 KRT77 KRT14 KRT76 KRT16 | 1.10e-21 | 284 | 17 | 13 | GO:0009913 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.44e-21 | 870 | 17 | 16 | GO:0030855 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 6.65e-21 | 957 | 17 | 16 | GO:0097435 |
| GeneOntologyBiologicalProcess | epithelium development | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 6.45e-18 | 1469 | 17 | 16 | GO:0060429 |
| GeneOntologyBiologicalProcess | peptide cross-linking | 1.34e-06 | 27 | 17 | 3 | GO:0018149 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 7.62e-05 | 16 | 17 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 8.63e-05 | 17 | 17 | 2 | GO:0003334 | |
| GeneOntologyBiologicalProcess | keratinocyte migration | 1.33e-04 | 21 | 17 | 2 | GO:0051546 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 2.93e-04 | 31 | 17 | 2 | GO:0051291 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 3.33e-04 | 33 | 17 | 2 | GO:0045684 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 5.14e-04 | 41 | 17 | 2 | GO:0061436 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 1.54e-03 | 71 | 17 | 2 | GO:0045682 | |
| GeneOntologyBiologicalProcess | humoral immune response | 2.16e-03 | 321 | 17 | 3 | GO:0006959 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 3.83e-03 | 113 | 17 | 2 | GO:0051262 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 5.34e-03 | 134 | 17 | 2 | GO:0061844 | |
| GeneOntologyBiologicalProcess | molting cycle | 6.65e-03 | 150 | 17 | 2 | GO:0042303 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 6.65e-03 | 150 | 17 | 2 | GO:0050830 | |
| GeneOntologyBiologicalProcess | hair cycle | 6.65e-03 | 150 | 17 | 2 | GO:0042633 | |
| GeneOntologyBiologicalProcess | wound healing | 7.19e-03 | 493 | 17 | 3 | GO:0042060 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 8.09e-03 | 166 | 17 | 2 | GO:0098773 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 8.15e-03 | 516 | 17 | 3 | GO:0016055 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 1.01e-02 | 186 | 17 | 2 | GO:0019730 | |
| GeneOntologyCellularComponent | keratin filament | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT16 | 4.32e-34 | 97 | 17 | 15 | GO:0045095 |
| GeneOntologyCellularComponent | intermediate filament | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.69e-31 | 227 | 17 | 16 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 4.18e-30 | 263 | 17 | 16 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.97e-21 | 899 | 17 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.53e-19 | 1179 | 17 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.71e-19 | 1187 | 17 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | cornified envelope | 5.91e-14 | 69 | 17 | 7 | GO:0001533 | |
| HumanPheno | Palmoplantar blistering | 5.70e-14 | 11 | 14 | 6 | HP:0007446 | |
| HumanPheno | Palmoplantar hyperkeratosis | 7.03e-14 | 129 | 14 | 10 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 8.23e-14 | 131 | 14 | 10 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 8.90e-14 | 132 | 14 | 10 | HP:0007556 | |
| HumanPheno | Hyperkeratosis | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 | 4.70e-13 | 233 | 14 | 11 | HP:0000962 |
| HumanPheno | Abnormality of keratinization | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 | 7.84e-13 | 244 | 14 | 11 | HP:0001035 |
| HumanPheno | Abnormality of the plantar skin of foot | 1.25e-12 | 171 | 14 | 10 | HP:0100872 | |
| HumanPheno | Palmoplantar keratoderma | 1.87e-12 | 114 | 14 | 9 | HP:0000982 | |
| HumanPheno | Abnormal blistering of the skin | 2.03e-12 | 115 | 14 | 9 | HP:0008066 | |
| HumanPheno | Blistering by anatomical location | 2.78e-11 | 26 | 14 | 6 | HP:0033800 | |
| HumanPheno | Congenital bullous ichthyosiform erythroderma | 3.57e-11 | 4 | 14 | 4 | HP:0007475 | |
| HumanPheno | Epidermal thickening | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 | 1.00e-10 | 379 | 14 | 11 | HP:0011368 |
| HumanPheno | Thickened skin | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 | 4.06e-10 | 431 | 14 | 11 | HP:0001072 |
| HumanPheno | Abnormal epidermal morphology | 1.80e-09 | 94 | 14 | 7 | HP:0011124 | |
| HumanPheno | Epidermal acanthosis | 3.00e-09 | 54 | 14 | 6 | HP:0025092 | |
| HumanPheno | White lesion of the oral mucosa | 6.67e-09 | 28 | 14 | 5 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 6.67e-09 | 28 | 14 | 5 | HP:0002745 | |
| HumanPheno | Onychogryposis | 8.04e-09 | 29 | 14 | 5 | HP:0001805 | |
| HumanPheno | Abnormal skin morphology of the palm | 8.24e-09 | 413 | 14 | 10 | HP:0040211 | |
| HumanPheno | Lower limb pain | 4.99e-08 | 41 | 14 | 5 | HP:0012514 | |
| HumanPheno | Eruptive vellus hair cyst | 6.60e-08 | 4 | 14 | 3 | HP:0025248 | |
| HumanPheno | Steatocystoma multiplex | 6.60e-08 | 4 | 14 | 3 | HP:0012035 | |
| HumanPheno | Abnormal palm morphology | 7.91e-08 | 521 | 14 | 10 | HP:0100871 | |
| HumanPheno | Hyperhidrosis | 1.02e-07 | 167 | 14 | 7 | HP:0000975 | |
| HumanPheno | Regional abnormality of skin | 1.14e-07 | 541 | 14 | 10 | HP:0011356 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 1.65e-07 | 5 | 14 | 3 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 1.65e-07 | 5 | 14 | 3 | HP:0030268 | |
| HumanPheno | Hypergranulosis | 2.54e-07 | 22 | 14 | 4 | HP:0025114 | |
| HumanPheno | Limb pain | 2.72e-07 | 57 | 14 | 5 | HP:0009763 | |
| HumanPheno | Onychogryposis of toenails | 5.75e-07 | 7 | 14 | 3 | HP:0008401 | |
| HumanPheno | Onychogryposis | 5.75e-07 | 7 | 14 | 3 | HP:0001819 | |
| HumanPheno | Skin erosion | 7.04e-07 | 28 | 14 | 4 | HP:0200041 | |
| HumanPheno | Abnormal fingernail morphology | 9.15e-07 | 230 | 14 | 7 | HP:0001231 | |
| HumanPheno | Knuckle pad | 9.18e-07 | 8 | 14 | 3 | HP:0032541 | |
| HumanPheno | Hypohidrosis or hyperhidrosis | 1.06e-06 | 235 | 14 | 7 | HP:0007550 | |
| HumanPheno | Onychogryposis of fingernail | 1.38e-06 | 9 | 14 | 3 | HP:0040036 | |
| HumanPheno | Congenital ichthyosiform erythroderma | 1.40e-06 | 33 | 14 | 4 | HP:0007431 | |
| HumanPheno | Abnormality of skin adnexa physiology | 1.57e-06 | 249 | 14 | 7 | HP:0025276 | |
| HumanPheno | Nail dystrophy | 1.84e-06 | 156 | 14 | 6 | HP:0008404 | |
| HumanPheno | Abnormal sweat gland morphology | 2.10e-06 | 260 | 14 | 7 | HP:0000971 | |
| HumanPheno | Diffuse palmoplantar hyperkeratosis | 2.69e-06 | 11 | 14 | 3 | HP:0007447 | |
| HumanPheno | Epidermal hyperkeratosis | 2.69e-06 | 11 | 14 | 3 | HP:0007543 | |
| HumanPheno | Angular cheilitis | 3.58e-06 | 12 | 14 | 3 | HP:0030318 | |
| HumanPheno | Hyperkeratotic papule | 4.65e-06 | 13 | 14 | 3 | HP:0045059 | |
| HumanPheno | Epidermoid cyst | 4.99e-06 | 45 | 14 | 4 | HP:0200040 | |
| HumanPheno | Palmoplantar hyperhidrosis | 5.91e-06 | 14 | 14 | 3 | HP:0007410 | |
| HumanPheno | Tonofilament clumping | 7.02e-06 | 2 | 14 | 2 | HP:0034067 | |
| HumanPheno | Focal friction-related palmoplantar hyperkeratosis | 7.02e-06 | 2 | 14 | 2 | HP:0007497 | |
| HumanPheno | Ear pain | 7.38e-06 | 15 | 14 | 3 | HP:0030766 | |
| HumanPheno | Cutaneous cyst | 8.29e-06 | 51 | 14 | 4 | HP:0025245 | |
| HumanPheno | Fingernail dysplasia | 9.06e-06 | 16 | 14 | 3 | HP:0100798 | |
| HumanPheno | Palmar hyperhidrosis | 9.06e-06 | 16 | 14 | 3 | HP:0006089 | |
| HumanPheno | Paronychia | 9.06e-06 | 16 | 14 | 3 | HP:0001818 | |
| HumanPheno | Abnormal nail morphology | 1.82e-05 | 516 | 14 | 8 | HP:0001597 | |
| HumanPheno | Erythema | 1.86e-05 | 133 | 14 | 5 | HP:0010783 | |
| HumanPheno | Generalized reticulate brown pigmentation | 2.10e-05 | 3 | 14 | 2 | HP:0007599 | |
| HumanPheno | Abnormality of the periungual region | 2.47e-05 | 22 | 14 | 3 | HP:0100803 | |
| HumanPheno | Abnormal oral mucosa morphology | 2.68e-05 | 381 | 14 | 7 | HP:0011830 | |
| HumanPheno | Nail dysplasia | 3.87e-05 | 264 | 14 | 6 | HP:0002164 | |
| HumanPheno | Acute episodes of neuropathic symptoms | 4.20e-05 | 4 | 14 | 2 | HP:0003489 | |
| HumanPheno | Foot pain | 4.20e-05 | 4 | 14 | 2 | HP:0025238 | |
| HumanPheno | Hyperparakeratosis | 4.20e-05 | 4 | 14 | 2 | HP:0040009 | |
| HumanPheno | Stratum basale cleavage | 4.20e-05 | 4 | 14 | 2 | HP:0034193 | |
| HumanPheno | Depigmentation/hyperpigmentation of skin | 4.20e-05 | 4 | 14 | 2 | HP:0007483 | |
| HumanPheno | Skin fragility with non-scarring blistering | 4.20e-05 | 4 | 14 | 2 | HP:0007585 | |
| HumanPheno | Smooth tongue | 4.20e-05 | 4 | 14 | 2 | HP:0010298 | |
| HumanPheno | Hoarse voice | 4.43e-05 | 159 | 14 | 5 | HP:0001609 | |
| HumanPheno | Supernumerary tooth | 6.36e-05 | 85 | 14 | 4 | HP:0011069 | |
| HumanPheno | Follicular hyperkeratosis | 6.42e-05 | 30 | 14 | 3 | HP:0007502 | |
| HumanPheno | Parakeratosis | 8.59e-05 | 33 | 14 | 3 | HP:0001036 | |
| HumanPheno | Impaired temperature sensation | 9.41e-05 | 34 | 14 | 3 | HP:0010829 | |
| HumanPheno | Abnormality of temperature sensation | 9.41e-05 | 34 | 14 | 3 | HP:0100772 | |
| HumanPheno | Intra-epidermal blistering | 1.05e-04 | 6 | 14 | 2 | HP:0033802 | |
| HumanPheno | Punctate palmoplantar hyperkeratosis | 1.05e-04 | 6 | 14 | 2 | HP:0007530 | |
| HumanPheno | Aplasia cutis congenita on trunk or limbs | 1.05e-04 | 6 | 14 | 2 | HP:0007589 | |
| HumanPheno | Fragile skin | 1.22e-04 | 37 | 14 | 3 | HP:0001030 | |
| HumanPheno | Impaired tactile sensation | 1.22e-04 | 37 | 14 | 3 | HP:0010830 | |
| HumanPheno | Natal tooth | 1.32e-04 | 38 | 14 | 3 | HP:0000695 | |
| HumanPheno | Localized skin lesion | 1.35e-04 | 897 | 14 | 9 | HP:0011355 | |
| HumanPheno | Reticulated skin pigmentation | 1.46e-04 | 7 | 14 | 2 | HP:0007427 | |
| HumanPheno | Pain in head and neck region | 1.54e-04 | 40 | 14 | 3 | HP:0046506 | |
| HumanPheno | Mottled pigmentation | 1.95e-04 | 8 | 14 | 2 | HP:0001070 | |
| HumanPheno | Cutaneous photosensitivity | 2.29e-04 | 118 | 14 | 4 | HP:0000992 | |
| HumanPheno | Advanced eruption of teeth | 2.34e-04 | 46 | 14 | 3 | HP:0006288 | |
| HumanPheno | Skin plaque | 2.50e-04 | 47 | 14 | 3 | HP:0200035 | |
| HumanPheno | Spotty hypopigmentation | 2.50e-04 | 9 | 14 | 2 | HP:0005590 | |
| HumanPheno | Spotty hyperpigmentation | 2.50e-04 | 9 | 14 | 2 | HP:0005585 | |
| HumanPheno | Acral blistering | 2.50e-04 | 9 | 14 | 2 | HP:0031045 | |
| HumanPheno | Upper limb pain | 2.50e-04 | 9 | 14 | 2 | HP:0012513 | |
| HumanPheno | Abnormal dermatological laboratory findings | 3.12e-04 | 10 | 14 | 2 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 3.12e-04 | 10 | 14 | 2 | HP:0003341 | |
| HumanPheno | Conjunctival nodule | 3.80e-04 | 11 | 14 | 2 | HP:0009903 | |
| HumanPheno | Subepidermal blistering | 3.80e-04 | 11 | 14 | 2 | HP:0033804 | |
| HumanPheno | Conjunctival hamartoma | 3.80e-04 | 11 | 14 | 2 | HP:0100780 | |
| HumanPheno | Abnormal exteroceptive sensation | 4.48e-04 | 259 | 14 | 5 | HP:0033747 | |
| HumanPheno | Erythematous papule | 4.56e-04 | 12 | 14 | 2 | HP:0030350 | |
| HumanPheno | Alopecia | 4.64e-04 | 261 | 14 | 5 | HP:0001596 | |
| HumanPheno | Cheilitis | 4.67e-04 | 58 | 14 | 3 | HP:0100825 | |
| HumanPheno | Ichthyosis | 4.92e-04 | 144 | 14 | 4 | HP:0008064 | |
| HumanPheno | Blistering by histological location | 5.38e-04 | 13 | 14 | 2 | HP:0033801 | |
| MousePheno | abnormal epidermal layer morphology | 1.75e-14 | 271 | 15 | 10 | MP:0001216 | |
| MousePheno | abnormal tongue epithelium morphology | 1.41e-13 | 27 | 15 | 6 | MP:0000764 | |
| MousePheno | abnormal esophagus morphology | 2.35e-13 | 66 | 15 | 7 | MP:0000467 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 3.45e-11 | 132 | 15 | 7 | MP:0001240 | |
| MousePheno | abnormal skin physiology | 1.67e-10 | 288 | 15 | 8 | MP:0005501 | |
| MousePheno | hyperkeratosis | 2.87e-10 | 90 | 15 | 6 | MP:0001242 | |
| MousePheno | abnormal tongue morphology | 1.50e-09 | 118 | 15 | 6 | MP:0000762 | |
| MousePheno | abnormal esophageal epithelium morphology | 2.03e-09 | 17 | 15 | 4 | MP:0000468 | |
| MousePheno | abnormal keratinocyte morphology | 2.07e-09 | 54 | 15 | 5 | MP:0002655 | |
| MousePheno | blistering | 9.01e-09 | 24 | 15 | 4 | MP:0001208 | |
| MousePheno | abnormal foot pad morphology | 1.27e-08 | 26 | 15 | 4 | MP:0000574 | |
| MousePheno | abnormal skin morphology | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT14 KRT76 KRT16 | 1.38e-08 | 1455 | 15 | 11 | MP:0002060 |
| MousePheno | hyperpigmentation | 1.73e-08 | 28 | 15 | 4 | MP:0001188 | |
| MousePheno | abnormal head morphology | 2.17e-08 | 1120 | 15 | 10 | MP:0000432 | |
| MousePheno | abnormal filiform papillae morphology | 3.49e-08 | 7 | 15 | 3 | MP:0000763 | |
| MousePheno | acanthosis | 1.03e-07 | 43 | 15 | 4 | MP:0001874 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 1.25e-07 | 45 | 15 | 4 | MP:0009611 | |
| MousePheno | abnormal mouth morphology | 1.27e-07 | 670 | 15 | 8 | MP:0000452 | |
| MousePheno | craniofacial phenotype | 1.52e-07 | 1372 | 15 | 10 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 1.52e-07 | 1372 | 15 | 10 | MP:0000428 | |
| MousePheno | abnormal skin appearance | 2.47e-07 | 473 | 15 | 7 | MP:0009931 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 5.59e-07 | 65 | 15 | 4 | MP:0001236 | |
| MousePheno | abnormal digestive system morphology | 9.63e-07 | 1233 | 15 | 9 | MP:0000462 | |
| MousePheno | abnormal facial morphology | 1.33e-06 | 910 | 15 | 8 | MP:0003743 | |
| MousePheno | abnormal skin pigmentation | 1.81e-06 | 87 | 15 | 4 | MP:0002095 | |
| MousePheno | digestive/alimentary phenotype | 5.05e-06 | 1500 | 15 | 9 | MP:0005381 | |
| MousePheno | abnormal epidermis stratum basale morphology | 7.60e-06 | 37 | 15 | 3 | MP:0001231 | |
| MousePheno | esophageal epithelium hyperplasia | 1.07e-05 | 5 | 15 | 2 | MP:0000466 | |
| MousePheno | abnormal palate morphology | 1.54e-05 | 321 | 15 | 5 | MP:0003755 | |
| MousePheno | scaly skin | 2.54e-05 | 55 | 15 | 3 | MP:0001192 | |
| MousePheno | abnormal skin coloration | 3.39e-05 | 182 | 15 | 4 | MP:0011239 | |
| MousePheno | hypergranulosis | 3.85e-05 | 9 | 15 | 2 | MP:0009600 | |
| MousePheno | abnormal autopod morphology | 3.93e-05 | 390 | 15 | 5 | MP:0000572 | |
| MousePheno | impaired skin barrier function | 4.00e-05 | 64 | 15 | 3 | MP:0002796 | |
| MousePheno | abnormal epidermis stratum granulosum morphology | 5.24e-05 | 70 | 15 | 3 | MP:0001239 | |
| MousePheno | thick epidermis stratum granulosum | 7.05e-05 | 12 | 15 | 2 | MP:0009599 | |
| MousePheno | increased tail pigmentation | 7.05e-05 | 12 | 15 | 2 | MP:0011276 | |
| MousePheno | thick epidermis | 7.82e-05 | 80 | 15 | 3 | MP:0001219 | |
| MousePheno | abnormal keratinocyte physiology | 8.11e-05 | 81 | 15 | 3 | MP:0003453 | |
| MousePheno | abnormal oral mucosa morphology | 9.71e-05 | 14 | 15 | 2 | MP:0003745 | |
| MousePheno | abnormal epidermis suprabasal layer morphology | 1.12e-04 | 15 | 15 | 2 | MP:0001233 | |
| MousePheno | abnormal cornea epithelium thickness | 1.28e-04 | 16 | 15 | 2 | MP:0020853 | |
| MousePheno | increased foot pigmentation | 1.28e-04 | 16 | 15 | 2 | MP:0030051 | |
| MousePheno | increased foot pad pigmentation | 1.28e-04 | 16 | 15 | 2 | MP:0000575 | |
| MousePheno | abnormal corneocyte morphology | 1.63e-04 | 18 | 15 | 2 | MP:0030605 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.67e-04 | 1269 | 15 | 7 | MP:0011111 | |
| MousePheno | skin inflammation | 1.75e-04 | 105 | 15 | 3 | MP:0004947 | |
| MousePheno | flaky skin | 2.23e-04 | 21 | 15 | 2 | MP:0001195 | |
| MousePheno | increased skin papilloma incidence | 2.45e-04 | 22 | 15 | 2 | MP:0002051 | |
| MousePheno | abnormal outer ear morphology | 2.54e-04 | 119 | 15 | 3 | MP:0002177 | |
| MousePheno | enlarged sebaceous gland | 2.68e-04 | 23 | 15 | 2 | MP:0000652 | |
| MousePheno | pigmentation phenotype | 3.60e-04 | 624 | 15 | 5 | MP:0001186 | |
| MousePheno | increased keratinocyte proliferation | 3.71e-04 | 27 | 15 | 2 | MP:0009583 | |
| MousePheno | abnormal foot pigmentation | 4.00e-04 | 28 | 15 | 2 | MP:0009379 | |
| MousePheno | abnormal limb morphology | 4.38e-04 | 1028 | 15 | 6 | MP:0002109 | |
| MousePheno | increased papilloma incidence | 5.57e-04 | 33 | 15 | 2 | MP:0002014 | |
| MousePheno | postnatal lethality | 5.83e-04 | 1084 | 15 | 6 | MP:0002082 | |
| MousePheno | abnormal tail morphology | 7.22e-04 | 403 | 15 | 4 | MP:0002111 | |
| MousePheno | abnormal tail pigmentation | 7.78e-04 | 39 | 15 | 2 | MP:0005174 | |
| MousePheno | abnormal keratinocyte proliferation | 8.60e-04 | 41 | 15 | 2 | MP:0009582 | |
| MousePheno | abnormal cornea epithelium morphology | 9.03e-04 | 42 | 15 | 2 | MP:0006000 | |
| MousePheno | increased skin tumor incidence | 1.04e-03 | 45 | 15 | 2 | MP:0010300 | |
| MousePheno | abnormal wound healing | 1.04e-03 | 193 | 15 | 3 | MP:0005023 | |
| MousePheno | postnatal lethality, complete penetrance | 1.05e-03 | 445 | 15 | 4 | MP:0011085 | |
| MousePheno | limbs/digits/tail phenotype | 1.29e-03 | 1258 | 15 | 6 | MP:0005371 | |
| MousePheno | thick skin | 1.38e-03 | 52 | 15 | 2 | MP:0001200 | |
| MousePheno | delayed wound healing | 1.43e-03 | 53 | 15 | 2 | MP:0002908 | |
| MousePheno | abnormal ocular surface morphology | 2.28e-03 | 67 | 15 | 2 | MP:0013754 | |
| MousePheno | epidermal hyperplasia | 2.28e-03 | 67 | 15 | 2 | MP:0001222 | |
| MousePheno | abnormal hard palate morphology | 2.28e-03 | 67 | 15 | 2 | MP:0003756 | |
| MousePheno | abnormal sebaceous gland morphology | 2.93e-03 | 76 | 15 | 2 | MP:0000647 | |
| MousePheno | increased integument system tumor incidence | 2.93e-03 | 76 | 15 | 2 | MP:0010293 | |
| MousePheno | abnormal holocrine gland morphology | 2.93e-03 | 76 | 15 | 2 | MP:0013543 | |
| MousePheno | abnormal tumor incidence | 3.85e-03 | 635 | 15 | 4 | MP:0002019 | |
| MousePheno | abnormal tumor susceptibility | 4.19e-03 | 650 | 15 | 4 | MP:0002166 | |
| MousePheno | perinatal lethality | 5.17e-03 | 1130 | 15 | 5 | MP:0002081 | |
| MousePheno | neoplasm | 6.88e-03 | 747 | 15 | 4 | MP:0002006 | |
| MousePheno | increased classified tumor incidence | 7.16e-03 | 381 | 15 | 3 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 7.32e-03 | 384 | 15 | 3 | MP:0020188 | |
| MousePheno | increased organ/body region tumor incidence | 7.91e-03 | 395 | 15 | 3 | MP:0010274 | |
| MousePheno | increased cell proliferation | 7.97e-03 | 396 | 15 | 3 | MP:0000351 | |
| MousePheno | abnormal organ/body region tumor incidence | 8.25e-03 | 401 | 15 | 3 | MP:0013152 | |
| MousePheno | neonatal lethality | 8.71e-03 | 799 | 15 | 4 | MP:0002058 | |
| MousePheno | decreased food intake | 9.21e-03 | 137 | 15 | 2 | MP:0011940 | |
| Domain | Intermediate_filament_CS | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 5.97e-40 | 63 | 17 | 16 | IPR018039 |
| Domain | IF | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 6.70e-39 | 72 | 17 | 16 | PS00226 |
| Domain | Filament | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 8.58e-39 | 73 | 17 | 16 | PF00038 |
| Domain | IF | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.76e-38 | 76 | 17 | 16 | IPR001664 |
| Domain | Filament | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.39e-35 | 71 | 17 | 15 | SM01391 |
| Domain | Keratin_I | KRT1 KRT3 KRT4 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.90e-26 | 44 | 17 | 11 | IPR002957 |
| Domain | Keratin_II | 7.24e-26 | 26 | 17 | 10 | IPR003054 | |
| Domain | Keratin_2_head | 4.15e-23 | 24 | 17 | 9 | PF16208 | |
| Domain | Keratin_2_head | 4.15e-23 | 24 | 17 | 9 | IPR032444 | |
| Domain | GrpE_coiled_coil | 2.31e-10 | 12 | 17 | 4 | IPR013805 | |
| Domain | Prefoldin | 4.41e-09 | 72 | 17 | 5 | IPR009053 | |
| Domain | HR1_rho-bd | 2.31e-04 | 25 | 17 | 2 | IPR011072 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.56e-32 | 129 | 17 | 16 | M27649 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 2.60e-29 | 87 | 17 | 14 | MM15351 |
| Pathway | REACTOME_KERATINIZATION | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 9.54e-29 | 217 | 17 | 16 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.13e-25 | 153 | 17 | 14 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 2.72e-18 | 502 | 17 | 14 | MM14537 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.83e-15 | 1432 | 17 | 16 | M509 |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 8.57e-10 | 40 | 17 | 5 | M48231 | |
| Pathway | WP_PANCREATIC_CANCER_SUBTYPES | 2.44e-05 | 48 | 17 | 3 | M48093 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 4.90e-05 | 9 | 17 | 2 | MM15117 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 7.48e-05 | 11 | 17 | 2 | M27372 | |
| Pathway | PID_DELTA_NP63_PATHWAY | 1.43e-03 | 47 | 17 | 2 | M236 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.42e-03 | 73 | 17 | 2 | MM15126 | |
| Pathway | PID_REG_GR_PATHWAY | 4.30e-03 | 82 | 17 | 2 | M115 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 5.38e-03 | 92 | 17 | 2 | M39441 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 5.84e-03 | 96 | 17 | 2 | MM14592 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 8.56e-03 | 117 | 17 | 2 | M19248 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.47e-02 | 155 | 17 | 2 | M522 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 2.05e-02 | 185 | 17 | 2 | M39718 | |
| Pubmed | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 2.85e-44 | 63 | 17 | 16 | 16831889 | |
| Pubmed | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 | 2.98e-41 | 57 | 17 | 15 | 31862882 | |
| Pubmed | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.47e-33 | 266 | 17 | 16 | 19380743 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 8.47e-32 | 84 | 17 | 13 | 29563501 |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 2.96e-28 | 91 | 17 | 12 | 34445801 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT6C KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.55e-25 | 564 | 17 | 15 | 21565611 |
| Pubmed | 2.04e-24 | 60 | 17 | 10 | 31220272 | ||
| Pubmed | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.17e-23 | 1153 | 17 | 16 | 29845934 | |
| Pubmed | 1.30e-22 | 46 | 17 | 9 | 36147463 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 1.30e-22 | 605 | 17 | 14 | 28977666 |
| Pubmed | 6.25e-22 | 54 | 17 | 9 | 35474131 | ||
| Pubmed | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT15 KRT16 | 4.60e-21 | 346 | 17 | 12 | 25324306 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT16 | 5.45e-21 | 218 | 17 | 11 | 35831895 |
| Pubmed | 1.47e-20 | 75 | 17 | 9 | 31527668 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6B KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 4.46e-20 | 630 | 17 | 13 | 36949045 |
| Pubmed | KRT1 KRT2 KRT4 KRT5 KRT6A KRT9 KRT10 KRT13 KRT14 KRT76 KRT15 KRT16 | 8.01e-20 | 438 | 17 | 12 | 21630459 | |
| Pubmed | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 2.96e-19 | 488 | 17 | 12 | 31324722 | |
| Pubmed | 5.07e-19 | 197 | 17 | 10 | 23686814 | ||
| Pubmed | 5.49e-19 | 24 | 17 | 7 | 30719818 | ||
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 6.93e-19 | 113 | 17 | 9 | 34474245 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 1.49e-18 | 558 | 17 | 12 | 27591049 |
| Pubmed | 2.28e-18 | 65 | 17 | 8 | 29795372 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 3.61e-18 | 135 | 17 | 9 | 29859926 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT15 KRT16 | 3.72e-18 | 1257 | 17 | 14 | 36526897 |
| Pubmed | KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT15 KRT16 | 7.49e-18 | 417 | 17 | 11 | 19199708 | |
| Pubmed | 1.46e-17 | 5 | 17 | 5 | 2458356 | ||
| Pubmed | 1.94e-17 | 162 | 17 | 9 | 15174051 | ||
| Pubmed | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 2.53e-17 | 1442 | 17 | 14 | 35575683 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 4.02e-17 | 16 | 17 | 6 | 12399393 | |
| Pubmed | 8.79e-17 | 191 | 17 | 9 | 33762435 | ||
| Pubmed | 1.36e-16 | 19 | 17 | 6 | 35173535 | ||
| Pubmed | 1.46e-16 | 107 | 17 | 8 | 32989256 | ||
| Pubmed | AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. | 2.72e-16 | 21 | 17 | 6 | 18824566 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 6.55e-16 | 238 | 17 | 9 | 35864588 | |
| Pubmed | 6.75e-16 | 24 | 17 | 6 | 27507811 | ||
| Pubmed | 8.17e-16 | 8 | 17 | 5 | 19515043 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 9.19e-16 | 247 | 17 | 9 | 39238192 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT6C KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT15 KRT16 | 1.62e-15 | 1415 | 17 | 13 | 28515276 |
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 1.84e-15 | 9 | 17 | 5 | 16180309 | |
| Pubmed | 2.38e-15 | 29 | 17 | 6 | 28049658 | ||
| Pubmed | 3.26e-15 | 284 | 17 | 9 | 29459677 | ||
| Pubmed | 3.67e-15 | 10 | 17 | 5 | 24940650 | ||
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 3.67e-15 | 10 | 17 | 5 | 10571739 | |
| Pubmed | 3.68e-15 | 31 | 17 | 6 | 20930145 | ||
| Pubmed | 3.82e-15 | 289 | 17 | 9 | 37132043 | ||
| Pubmed | 5.05e-15 | 298 | 17 | 9 | 30737378 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 6.16e-15 | 169 | 17 | 8 | 23084401 | |
| Pubmed | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT16 | 1.01e-14 | 803 | 17 | 11 | 36517590 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.70e-14 | 580 | 17 | 10 | 35676659 | |
| Pubmed | 3.90e-14 | 4 | 17 | 4 | 7679677 | ||
| Pubmed | 3.90e-14 | 4 | 17 | 4 | 32179842 | ||
| Pubmed | Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. | 4.06e-14 | 45 | 17 | 6 | 28973166 | |
| Pubmed | 4.06e-14 | 45 | 17 | 6 | 30619335 | ||
| Pubmed | Multiple roles of Notch signaling in the regulation of epidermal development. | 4.37e-14 | 15 | 17 | 5 | 18410734 | |
| Pubmed | 1.24e-13 | 245 | 17 | 8 | 35652658 | ||
| Pubmed | 1.25e-13 | 18 | 17 | 5 | 20335364 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.38e-13 | 430 | 17 | 9 | 38172120 | |
| Pubmed | Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. | 1.69e-13 | 19 | 17 | 5 | 17002498 | |
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 1.95e-13 | 5 | 17 | 4 | 1713141 | |
| Pubmed | 1.95e-13 | 5 | 17 | 4 | 9873228 | ||
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 1.95e-13 | 5 | 17 | 4 | 12557214 | |
| Pubmed | 1.95e-13 | 5 | 17 | 4 | 20301457 | ||
| Pubmed | 2.24e-13 | 59 | 17 | 6 | 26371508 | ||
| Pubmed | HDM2-binding partners: interaction with translation elongation factor EF1alpha. | 2.96e-13 | 21 | 17 | 5 | 17373842 | |
| Pubmed | 3.05e-13 | 62 | 17 | 6 | 26644517 | ||
| Pubmed | High proliferation and delamination during skin epidermal stratification. | 3.83e-13 | 22 | 17 | 5 | 34050161 | |
| Pubmed | 4.32e-13 | 286 | 17 | 8 | 32041737 | ||
| Pubmed | 5.85e-13 | 6 | 17 | 4 | 7525178 | ||
| Pubmed | Development, structure, and keratin expression in C57BL/6J mouse eccrine glands. | 5.85e-13 | 6 | 17 | 4 | 22135020 | |
| Pubmed | Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. | 5.85e-13 | 6 | 17 | 4 | 14638864 | |
| Pubmed | 5.85e-13 | 6 | 17 | 4 | 16239341 | ||
| Pubmed | Transcription Factor MafB Coordinates Epidermal Keratinocyte Differentiation. | 6.17e-13 | 24 | 17 | 5 | 27208706 | |
| Pubmed | 7.24e-13 | 305 | 17 | 8 | 33194618 | ||
| Pubmed | 7.71e-13 | 25 | 17 | 5 | 23132931 | ||
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 1.17e-12 | 27 | 17 | 5 | 27807348 | |
| Pubmed | 1.33e-12 | 329 | 17 | 8 | 35562734 | ||
| Pubmed | Regulation of epidermal differentiation by a Distal-less homeodomain gene. | 1.37e-12 | 7 | 17 | 4 | 8991098 | |
| Pubmed | 1.37e-12 | 7 | 17 | 4 | 10191051 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 2.34e-12 | 353 | 17 | 8 | 27545878 | |
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 2.46e-12 | 31 | 17 | 5 | 37115925 | |
| Pubmed | Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. | 2.73e-12 | 8 | 17 | 4 | 19494829 | |
| Pubmed | Identification of trichoplein, a novel keratin filament-binding protein. | 2.73e-12 | 8 | 17 | 4 | 15731013 | |
| Pubmed | Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8. | 2.73e-12 | 8 | 17 | 4 | 24449888 | |
| Pubmed | 2.73e-12 | 8 | 17 | 4 | 33294854 | ||
| Pubmed | 4.91e-12 | 9 | 17 | 4 | 16093647 | ||
| Pubmed | RIP4 regulates epidermal differentiation and cutaneous inflammation. | 4.91e-12 | 9 | 17 | 4 | 19626033 | |
| Pubmed | Aurora kinase-A deficiency during skin development impairs cell division and stratification. | 4.91e-12 | 9 | 17 | 4 | 22832491 | |
| Pubmed | 4.91e-12 | 9 | 17 | 4 | 15737194 | ||
| Pubmed | 4.95e-12 | 641 | 17 | 9 | 36057605 | ||
| Pubmed | 6.30e-12 | 37 | 17 | 5 | 17151017 | ||
| Pubmed | Immunolocalization patterns of cytokeratins during salivary acinar cell development in mice. | 8.19e-12 | 10 | 17 | 4 | 29181608 | |
| Pubmed | Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. | 9.51e-12 | 40 | 17 | 5 | 21151833 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 1.17e-11 | 1070 | 17 | 10 | 23533145 | |
| Pubmed | 1.29e-11 | 11 | 17 | 4 | 32853985 | ||
| Pubmed | 1.29e-11 | 11 | 17 | 4 | 16085486 | ||
| Pubmed | 2.47e-11 | 48 | 17 | 5 | 35247391 | ||
| Pubmed | 2.78e-11 | 13 | 17 | 4 | 8999895 | ||
| Pubmed | Fate and plasticity of the epidermis in response to congenital activation of BRAF. | 2.78e-11 | 13 | 17 | 4 | 25202828 | |
| Pubmed | 3.90e-11 | 14 | 17 | 4 | 32109382 | ||
| Pubmed | Lymphotoxin-beta regulates periderm differentiation during embryonic skin development. | 3.90e-11 | 14 | 17 | 4 | 17673451 | |
| Interaction | RNF208 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 | 1.10e-35 | 75 | 17 | 15 | int:RNF208 |
| Interaction | KRT7 interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 5.12e-29 | 80 | 17 | 13 | int:KRT7 |
| Interaction | KRT84 interactions | KRT6C KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 6.06e-29 | 49 | 17 | 12 | int:KRT84 |
| Interaction | DES interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.23e-27 | 158 | 17 | 14 | int:DES |
| Interaction | KRT75 interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 8.85e-27 | 181 | 17 | 14 | int:KRT75 |
| Interaction | KRT5 interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 2.24e-26 | 193 | 17 | 14 | int:KRT5 |
| Interaction | KRT6A interactions | KRT6C KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 7.02e-25 | 160 | 17 | 13 | int:KRT6A |
| Interaction | KRT25 interactions | 1.17e-24 | 35 | 17 | 10 | int:KRT25 | |
| Interaction | ZUP1 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 2.17e-24 | 174 | 17 | 13 | int:ZUP1 |
| Interaction | KRT19 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 5.23e-24 | 282 | 17 | 14 | int:KRT19 |
| Interaction | PRPH interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 1.83e-23 | 204 | 17 | 13 | int:PRPH |
| Interaction | KRT28 interactions | 2.29e-22 | 30 | 17 | 9 | int:KRT28 | |
| Interaction | CRK interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 2.50e-22 | 370 | 17 | 14 | int:CRK |
| Interaction | KRT17 interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT16 | 3.05e-22 | 252 | 17 | 13 | int:KRT17 |
| Interaction | KRT18 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 1.46e-21 | 419 | 17 | 14 | int:KRT18 |
| Interaction | KRT8 interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.01e-21 | 441 | 17 | 14 | int:KRT8 |
| Interaction | KRT16 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT10 KRT77 KRT76 KRT16 | 3.22e-21 | 197 | 17 | 12 | int:KRT16 |
| Interaction | KRT36 interactions | 4.51e-21 | 74 | 17 | 10 | int:KRT36 | |
| Interaction | HEXIM1 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 4.52e-21 | 913 | 17 | 16 | int:HEXIM1 |
| Interaction | EFNA1 interactions | 1.47e-19 | 103 | 17 | 10 | int:EFNA1 | |
| Interaction | KRT15 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT77 KRT76 KRT15 | 2.21e-19 | 178 | 17 | 11 | int:KRT15 |
| Interaction | EFNA3 interactions | 2.40e-19 | 108 | 17 | 10 | int:EFNA3 | |
| Interaction | KRT35 interactions | 3.20e-19 | 111 | 17 | 10 | int:KRT35 | |
| Interaction | KRT20 interactions | 3.74e-19 | 63 | 17 | 9 | int:KRT20 | |
| Interaction | KRT13 interactions | 5.05e-19 | 116 | 17 | 10 | int:KRT13 | |
| Interaction | KRT14 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT77 KRT14 KRT76 | 5.18e-19 | 192 | 17 | 11 | int:KRT14 |
| Interaction | SHC1 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 5.37e-18 | 362 | 17 | 12 | int:SHC1 |
| Interaction | PHTF1 interactions | 5.60e-18 | 20 | 17 | 7 | int:PHTF1 | |
| Interaction | CHD3 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 HIC1 KRT10 KRT77 KRT14 KRT16 | 6.07e-18 | 757 | 17 | 14 | int:CHD3 |
| Interaction | IQCB1 interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT15 KRT16 | 7.00e-18 | 370 | 17 | 12 | int:IQCB1 |
| Interaction | UBASH3B interactions | 1.14e-17 | 157 | 17 | 10 | int:UBASH3B | |
| Interaction | KRT33B interactions | 1.50e-17 | 93 | 17 | 9 | int:KRT33B | |
| Interaction | LARP7 interactions | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 1.52e-17 | 1113 | 17 | 15 | int:LARP7 |
| Interaction | KRT77 interactions | 2.03e-17 | 96 | 17 | 9 | int:KRT77 | |
| Interaction | MEPCE interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.56e-17 | 859 | 17 | 14 | int:MEPCE |
| Interaction | WTAP interactions | 9.92e-17 | 194 | 17 | 10 | int:WTAP | |
| Interaction | KRT27 interactions | 1.50e-16 | 202 | 17 | 10 | int:KRT27 | |
| Interaction | INPPL1 interactions | 2.69e-16 | 214 | 17 | 10 | int:INPPL1 | |
| Interaction | EPS15 interactions | 3.56e-16 | 220 | 17 | 10 | int:EPS15 | |
| Interaction | MINDY4 interactions | 4.73e-16 | 73 | 17 | 8 | int:MINDY4 | |
| Interaction | KRT26 interactions | 4.83e-16 | 35 | 17 | 7 | int:KRT26 | |
| Interaction | PIK3R2 interactions | 5.59e-16 | 230 | 17 | 10 | int:PIK3R2 | |
| Interaction | MKS1 interactions | 6.30e-16 | 139 | 17 | 9 | int:MKS1 | |
| Interaction | KRT2 interactions | 7.25e-16 | 236 | 17 | 10 | int:KRT2 | |
| Interaction | NPHP4 interactions | 7.25e-16 | 236 | 17 | 10 | int:NPHP4 | |
| Interaction | KRT1 interactions | 7.90e-16 | 238 | 17 | 10 | int:KRT1 | |
| Interaction | EFNA4 interactions | 8.24e-16 | 239 | 17 | 10 | int:EFNA4 | |
| Interaction | VIM interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT10 KRT77 KRT14 KRT76 KRT15 KRT16 | 1.21e-15 | 804 | 17 | 13 | int:VIM |
| Interaction | DDX39B interactions | KRT6C KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT16 | 1.27e-15 | 570 | 17 | 12 | int:DDX39B |
| Interaction | AHI1 interactions | 1.38e-15 | 83 | 17 | 8 | int:AHI1 | |
| Interaction | KIFC3 interactions | 1.41e-15 | 252 | 17 | 10 | int:KIFC3 | |
| Interaction | KRT76 interactions | 1.53e-15 | 84 | 17 | 8 | int:KRT76 | |
| Interaction | RNF8 interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT16 | 3.21e-15 | 421 | 17 | 11 | int:RNF8 |
| Interaction | AP2M1 interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT14 KRT16 | 4.06e-15 | 430 | 17 | 11 | int:AP2M1 |
| Interaction | KRT38 interactions | 4.46e-15 | 172 | 17 | 9 | int:KRT38 | |
| Interaction | DDX3X interactions | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 6.24e-15 | 651 | 17 | 12 | int:DDX3X |
| Interaction | KRT37 interactions | 6.47e-15 | 100 | 17 | 8 | int:KRT37 | |
| Interaction | CHD4 interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 8.88e-15 | 938 | 17 | 13 | int:CHD4 |
| Interaction | KRT10 interactions | 9.58e-15 | 187 | 17 | 9 | int:KRT10 | |
| Interaction | KRT24 interactions | 1.26e-14 | 54 | 17 | 7 | int:KRT24 | |
| Interaction | KRT12 interactions | 1.78e-14 | 24 | 17 | 6 | int:KRT12 | |
| Interaction | FGD5 interactions | 2.42e-14 | 207 | 17 | 9 | int:FGD5 | |
| Interaction | CBL interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT14 KRT16 | 3.01e-14 | 516 | 17 | 11 | int:CBL |
| Interaction | KRT6B interactions | 6.32e-14 | 132 | 17 | 8 | int:KRT6B | |
| Interaction | COPS5 interactions | KRT6C KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT76 KRT16 | 7.08e-14 | 1102 | 17 | 13 | int:COPS5 |
| Interaction | CUL5 interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 | 8.44e-14 | 567 | 17 | 11 | int:CUL5 |
| Interaction | CUL2 interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT9 KRT10 KRT13 KRT14 KRT76 KRT16 | 1.33e-13 | 591 | 17 | 11 | int:CUL2 |
| Interaction | KRT6C interactions | 1.54e-13 | 76 | 17 | 7 | int:KRT6C | |
| Interaction | CYLD interactions | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 1.92e-13 | 868 | 17 | 12 | int:CYLD |
| Interaction | RPS6KB2 interactions | 1.98e-13 | 261 | 17 | 9 | int:RPS6KB2 | |
| Interaction | TIMP2 interactions | 3.40e-13 | 277 | 17 | 9 | int:TIMP2 | |
| Interaction | KRT3 interactions | 4.45e-13 | 88 | 17 | 7 | int:KRT3 | |
| Interaction | KRT31 interactions | 5.04e-13 | 453 | 17 | 10 | int:KRT31 | |
| Interaction | EIF3F interactions | 6.18e-13 | 296 | 17 | 9 | int:EIF3F | |
| Interaction | INVS interactions | 1.04e-12 | 99 | 17 | 7 | int:INVS | |
| Interaction | DIRAS2 interactions | 2.65e-12 | 52 | 17 | 6 | int:DIRAS2 | |
| Interaction | METTL14 interactions | 3.99e-12 | 558 | 17 | 10 | int:METTL14 | |
| Interaction | KRT72 interactions | 5.85e-12 | 59 | 17 | 6 | int:KRT72 | |
| Interaction | KRT79 interactions | 5.85e-12 | 59 | 17 | 6 | int:KRT79 | |
| Interaction | PHGDH interactions | 6.56e-12 | 385 | 17 | 9 | int:PHGDH | |
| Interaction | ALB interactions | 7.53e-12 | 391 | 17 | 9 | int:ALB | |
| Interaction | RLIM interactions | 7.71e-12 | 392 | 17 | 9 | int:RLIM | |
| Interaction | NEDD8 interactions | 7.89e-12 | 393 | 17 | 9 | int:NEDD8 | |
| Interaction | CUL1 interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT13 KRT14 KRT16 | 9.59e-12 | 876 | 17 | 11 | int:CUL1 |
| Interaction | KRT40 interactions | 1.91e-11 | 434 | 17 | 9 | int:KRT40 | |
| Interaction | HNRNPA1 interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT14 KRT15 KRT16 | 2.17e-11 | 945 | 17 | 11 | int:HNRNPA1 |
| Interaction | KRT34 interactions | 2.98e-11 | 283 | 17 | 8 | int:KRT34 | |
| Interaction | METTL3 interactions | 3.34e-11 | 287 | 17 | 8 | int:METTL3 | |
| Interaction | THRB interactions | 9.16e-11 | 186 | 17 | 7 | int:THRB | |
| Interaction | KRT74 interactions | 9.59e-11 | 37 | 17 | 5 | int:KRT74 | |
| Interaction | PRPF8 interactions | 1.03e-10 | 776 | 17 | 10 | int:PRPF8 | |
| Interaction | CFTR interactions | KRT6C KRT1 KRT2 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT16 | 1.03e-10 | 1480 | 17 | 12 | int:CFTR |
| Interaction | GRB2 interactions | 1.49e-10 | 806 | 17 | 10 | int:GRB2 | |
| Interaction | FBP1 interactions | 1.55e-10 | 348 | 17 | 8 | int:FBP1 | |
| Interaction | NPHP3 interactions | 1.87e-10 | 42 | 17 | 5 | int:NPHP3 | |
| Interaction | TEDC2 interactions | 1.88e-10 | 206 | 17 | 7 | int:TEDC2 | |
| Interaction | KRT71 interactions | 2.11e-10 | 43 | 17 | 5 | int:KRT71 | |
| Interaction | PTMA interactions | 2.30e-10 | 212 | 17 | 7 | int:PTMA | |
| Interaction | KRT32 interactions | 2.38e-10 | 44 | 17 | 5 | int:KRT32 | |
| Interaction | DDX24 interactions | 3.21e-10 | 596 | 17 | 9 | int:DDX24 | |
| Cytoband | 12q13.13 | 4.18e-25 | 67 | 17 | 10 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 7.28e-17 | 423 | 17 | 10 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.30e-08 | 473 | 17 | 6 | chr17q21 | |
| Cytoband | 17q21.2 | 3.07e-04 | 70 | 17 | 2 | 17q21.2 | |
| GeneFamily | Keratins, type II | 1.59e-25 | 27 | 17 | 10 | 609 | |
| GeneFamily | Keratins, type I | 9.51e-14 | 28 | 17 | 6 | 608 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 2.82e-17 | 67 | 17 | 8 | M40299 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 7.07e-14 | 173 | 17 | 8 | M650 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 2.69e-13 | 204 | 17 | 8 | MM966 | |
| Coexpression | JAEGER_METASTASIS_DN | 1.89e-12 | 260 | 17 | 8 | M10702 | |
| Coexpression | LIU_CDX2_TARGETS_DN | 8.46e-12 | 8 | 17 | 4 | M19218 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 2.84e-11 | 204 | 17 | 7 | MM17090 | |
| Coexpression | DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS | 1.50e-10 | 129 | 17 | 6 | M40122 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_UP | 1.65e-10 | 15 | 17 | 4 | M13308 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_B_CELL_AGEING | 4.36e-09 | 100 | 17 | 5 | MM3697 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | 9.92e-09 | 473 | 17 | 7 | M4306 | |
| Coexpression | GU_PDEF_TARGETS_DN | 1.09e-08 | 40 | 17 | 4 | M10480 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS | 2.38e-08 | 140 | 17 | 5 | M40004 | |
| Coexpression | KRAS.LUNG_UP.V1_DN | 2.55e-08 | 142 | 17 | 5 | M2893 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 4.36e-08 | 56 | 17 | 4 | MM3852 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 6.45e-08 | 13 | 17 | 3 | MM743 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | 9.91e-08 | 662 | 17 | 7 | M8124 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 1.02e-07 | 69 | 17 | 4 | M2533 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 1.41e-07 | 200 | 17 | 5 | M5956 | |
| Coexpression | DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS | 1.64e-07 | 206 | 17 | 5 | M40237 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 1.64e-07 | 206 | 17 | 5 | M14134 | |
| Coexpression | MURAKAMI_UV_RESPONSE_24HR | 2.57e-07 | 20 | 17 | 3 | M17175 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | 2.86e-07 | 457 | 17 | 6 | M14507 | |
| Coexpression | MURAKAMI_UV_RESPONSE_6HR_DN | 2.99e-07 | 21 | 17 | 3 | M16756 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN | 3.27e-07 | 92 | 17 | 4 | M3672 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | 1.23e-06 | 587 | 17 | 6 | M17572 | |
| Coexpression | LEI_MYB_TARGETS | 1.51e-06 | 323 | 17 | 5 | M863 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN | 1.53e-06 | 324 | 17 | 5 | M2700 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN | 1.74e-06 | 37 | 17 | 3 | M16944 | |
| Coexpression | KRAS.300_UP.V1_DN | 1.76e-06 | 140 | 17 | 4 | M2874 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 2.25e-06 | 149 | 17 | 4 | M45703 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 2.30e-06 | 352 | 17 | 5 | MM3788 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | 3.52e-06 | 384 | 17 | 5 | M12527 | |
| Coexpression | KRAS.50_UP.V1_DN | 3.61e-06 | 47 | 17 | 3 | M2876 | |
| Coexpression | DOANE_BREAST_CANCER_ESR1_DN | 3.61e-06 | 47 | 17 | 3 | M8570 | |
| Coexpression | CROMER_TUMORIGENESIS_DN | 4.10e-06 | 49 | 17 | 3 | M16948 | |
| Coexpression | GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 4.99e-06 | 182 | 17 | 4 | M7624 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL | 6.29e-06 | 193 | 17 | 4 | M45706 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 9.93e-06 | 843 | 17 | 6 | M2356 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL | 1.17e-05 | 226 | 17 | 4 | M45709 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 1.21e-05 | 70 | 17 | 3 | M40002 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | 1.36e-05 | 891 | 17 | 6 | M41654 | |
| Coexpression | DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS | 1.59e-05 | 244 | 17 | 4 | M40175 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL | 2.22e-05 | 266 | 17 | 4 | M45715 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 2.60e-05 | 12 | 17 | 2 | M1769 | |
| Coexpression | KRAS.600_UP.V1_DN | 2.68e-05 | 279 | 17 | 4 | M2880 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 2.87e-05 | 284 | 17 | 4 | M2885 | |
| Coexpression | INAMURA_LUNG_CANCER_SCC_UP | 3.08e-05 | 13 | 17 | 2 | M1253 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP | 3.12e-05 | 96 | 17 | 3 | M5549 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN | 3.59e-05 | 14 | 17 | 2 | M34015 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 3.61e-05 | 301 | 17 | 4 | M45708 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 3.74e-05 | 102 | 17 | 3 | M14455 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 4.73e-05 | 16 | 17 | 2 | M1122 | |
| Coexpression | MACLACHLAN_BRCA1_TARGETS_DN | 4.73e-05 | 16 | 17 | 2 | M10593 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN | 5.08e-05 | 113 | 17 | 3 | M9524 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS | 6.73e-05 | 19 | 17 | 2 | M39272 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 6.73e-05 | 19 | 17 | 2 | M1126 | |
| Coexpression | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP | 7.02e-05 | 126 | 17 | 3 | M12795 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 7.47e-05 | 20 | 17 | 2 | MM491 | |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 7.47e-05 | 20 | 17 | 2 | M48357 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_UP | 9.40e-05 | 139 | 17 | 3 | M2534 | |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_DN | 9.80e-05 | 141 | 17 | 3 | M2898 | |
| Coexpression | KRAS.PROSTATE_UP.V1_DN | 9.80e-05 | 141 | 17 | 3 | M2901 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 9.94e-05 | 23 | 17 | 2 | MM492 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_DN | 9.94e-05 | 23 | 17 | 2 | M2176 | |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN | 1.07e-04 | 145 | 17 | 3 | M11513 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 1.37e-04 | 158 | 17 | 3 | MM3851 | |
| Coexpression | MA_RAT_AGING_DN | 1.45e-04 | 161 | 17 | 3 | M46419 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 1.64e-04 | 445 | 17 | 4 | M3645 | |
| Coexpression | MA_RAT_AGING_DN | 1.70e-04 | 170 | 17 | 3 | MM16097 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS | 1.86e-04 | 175 | 17 | 3 | MM3643 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 1.86e-04 | 175 | 17 | 3 | MM3823 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN | 1.86e-04 | 175 | 17 | 3 | M6750 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_HORIZONTAL_BASAL_CELLS | 2.07e-04 | 33 | 17 | 2 | M39273 | |
| Coexpression | AKT_UP.V1_DN | 2.26e-04 | 187 | 17 | 3 | M2666 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.42e-04 | 493 | 17 | 4 | M19391 | |
| Coexpression | GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP | 2.48e-04 | 193 | 17 | 3 | M7943 | |
| Coexpression | LEF1_UP.V1_UP | 2.51e-04 | 194 | 17 | 3 | M2905 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 2.71e-04 | 199 | 17 | 3 | M5159 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 2.75e-04 | 200 | 17 | 3 | M8212 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP | 2.75e-04 | 200 | 17 | 3 | M8201 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP | 2.75e-04 | 200 | 17 | 3 | M8203 | |
| Coexpression | AMIT_SERUM_RESPONSE_480_MCF10A | 2.89e-04 | 39 | 17 | 2 | M8202 | |
| Coexpression | OSADA_ASCL1_TARGETS_UP | 4.03e-04 | 46 | 17 | 2 | M8556 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 4.98e-04 | 1088 | 17 | 5 | MM3699 | |
| Coexpression | HUPER_BREAST_BASAL_VS_LUMINAL_UP | 5.35e-04 | 53 | 17 | 2 | M13422 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_EPIDERMAL_CELL_AGEING | 5.70e-04 | 618 | 17 | 4 | MM3829 | |
| Coexpression | AMIT_SERUM_RESPONSE_240_MCF10A | 6.19e-04 | 57 | 17 | 2 | M2777 | |
| Coexpression | ONDER_CDH1_TARGETS_3_DN | 6.63e-04 | 59 | 17 | 2 | M11790 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 6.74e-04 | 646 | 17 | 4 | M2419 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 7.94e-04 | 675 | 17 | 4 | MM1073 | |
| Coexpression | LEE_LIVER_CANCER_CIPROFIBRATE_DN | 8.29e-04 | 66 | 17 | 2 | M11640 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 8.57e-04 | 689 | 17 | 4 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 8.81e-04 | 694 | 17 | 4 | MM1039 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.01e-03 | 73 | 17 | 2 | M5618 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.12e-03 | 324 | 17 | 3 | MM3701 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 1.13e-03 | 77 | 17 | 2 | M40001 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL | 1.17e-03 | 329 | 17 | 3 | M2631 | |
| Coexpression | FARMER_BREAST_CANCER_BASAL_VS_LULMINAL | 1.17e-03 | 329 | 17 | 3 | M5652 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 1.18e-03 | 79 | 17 | 2 | M40003 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 1.28e-03 | 82 | 17 | 2 | MM3777 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 1.54e-17 | 98 | 17 | 9 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | esophagus | 7.56e-14 | 247 | 17 | 9 | esophagus | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 1.67e-13 | 427 | 17 | 10 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 4.28e-12 | 59 | 17 | 6 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | skin | 1.87e-11 | 456 | 17 | 9 | skin | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 2.62e-11 | 79 | 17 | 6 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_500 | 3.97e-11 | 496 | 17 | 9 | PCBC_ctl_BronchioEpithel_500 | |
| CoexpressionAtlas | BM Top 100 - esophagus | 4.41e-11 | 86 | 17 | 6 | BM Top 100 - esophagus | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.96e-11 | 325 | 17 | 8 | Arv_EB-LF_2500_K3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_100 | 9.83e-11 | 98 | 17 | 6 | PCBC_ctl_SmallAirwayEpithel_100 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 1.31e-10 | 206 | 17 | 7 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.92e-10 | 123 | 17 | 6 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | BM Top 100 - vagina | 3.07e-09 | 76 | 17 | 5 | BM Top 100 - vagina | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 3.52e-09 | 25 | 17 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_3 | 4.53e-09 | 82 | 17 | 5 | Facebase_ST1_Univ_500_3 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_100 | 5.12e-09 | 84 | 17 | 5 | Facebase_ST1_Univ_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_100 | 6.12e-09 | 87 | 17 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_500 | 1.46e-08 | 406 | 17 | 7 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 1.61e-08 | 981 | 17 | 9 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_1000 | 1.74e-08 | 990 | 17 | 9 | PCBC_ctl_BronchioEpithel_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 3.01e-08 | 451 | 17 | 7 | GSM538280_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_500 | 5.54e-08 | 493 | 17 | 7 | PCBC_ctl_SmallAirwayEpithel_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | 7.39e-08 | 805 | 17 | 8 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | 9.51e-08 | 150 | 17 | 5 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_500 | 1.43e-07 | 61 | 17 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 1.67e-07 | 168 | 17 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | BM Top 100 - tonsil | 2.49e-07 | 70 | 17 | 4 | BM Top 100 - tonsil | |
| CoexpressionAtlas | BM Top 100 - trachea | 2.80e-07 | 72 | 17 | 4 | BM Top 100 - trachea | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 3.08e-07 | 969 | 17 | 8 | PCBC_MESO-5_blastocyst_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 3.30e-07 | 75 | 17 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | 3.54e-07 | 987 | 17 | 8 | PCBC_ctl_SmallAirwayEpithel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_100 | 3.87e-07 | 78 | 17 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_500 | 3.87e-07 | 78 | 17 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_100 | 4.10e-07 | 19 | 17 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k3 | |
| CoexpressionAtlas | BM Top 100 - tongue main corpus | 4.28e-07 | 80 | 17 | 4 | BM Top 100 - tongue main corpus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | 4.53e-07 | 401 | 17 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 | |
| CoexpressionAtlas | BM Top 100 - oral mucosa | 4.97e-07 | 83 | 17 | 4 | BM Top 100 - oral mucosa | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 5.21e-07 | 84 | 17 | 4 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 6.46e-07 | 426 | 17 | 6 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 7.20e-07 | 91 | 17 | 4 | GSM538280_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 1.47e-06 | 800 | 17 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 1.57e-06 | 496 | 17 | 6 | Arv_EB-LF_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.18e-06 | 120 | 17 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_200 | 2.29e-06 | 33 | 17 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_200 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K1 | 3.09e-06 | 131 | 17 | 4 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_200 | 3.83e-06 | 39 | 17 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_200 | 3.83e-06 | 39 | 17 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_200 | 4.46e-06 | 41 | 17 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200_k3 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | 5.92e-06 | 987 | 17 | 7 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 6.35e-06 | 157 | 17 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 6.76e-06 | 47 | 17 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.02e-06 | 161 | 17 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#4_top-relative-expression-ranked_500 | 9.19e-06 | 52 | 17 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 9.75e-06 | 384 | 17 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 1.03e-05 | 388 | 17 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | EB cord blood_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.11e-05 | 181 | 17 | 4 | PCBC_ratio_EB cord blood_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | 1.22e-05 | 402 | 17 | 5 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_500 | 1.35e-05 | 59 | 17 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 1.67e-05 | 429 | 17 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_500 | 1.89e-05 | 66 | 17 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.94e-05 | 769 | 17 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_4 | 2.19e-05 | 215 | 17 | 4 | Facebase_ST1_Univ_500_4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_500 | 2.26e-05 | 70 | 17 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k4 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.86e-05 | 230 | 17 | 4 | ratio_DE_vs_SC_1000_K4 | |
| CoexpressionAtlas | BM Top 100 - bronchus | 2.89e-05 | 76 | 17 | 3 | BM Top 100 - bronchus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.12e-05 | 78 | 17 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_100 | 3.30e-05 | 11 | 17 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 3.30e-05 | 11 | 17 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_100 | 3.96e-05 | 12 | 17 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_100_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 4.04e-05 | 85 | 17 | 3 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_100 | 4.64e-05 | 89 | 17 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.12e-05 | 92 | 17 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 6.18e-05 | 98 | 17 | 3 | Arv_EB-LF_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#2_top-relative-expression-ranked_500 | 7.60e-05 | 105 | 17 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k2 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | 7.64e-05 | 981 | 17 | 6 | Arv_EB-LF_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.26e-05 | 108 | 17 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.26e-05 | 108 | 17 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.26e-05 | 108 | 17 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#5 | 9.01e-05 | 309 | 17 | 4 | ratio_EB_vs_SC_2500_K5 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.02e-04 | 319 | 17 | 4 | ratio_DE_vs_SC_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.07e-04 | 118 | 17 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 1.26e-04 | 21 | 17 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k1 | |
| CoexpressionAtlas | PP_MEP_top-relative-expression-ranked_500_k-means-cluster#5 | 1.26e-04 | 21 | 17 | 2 | PP_MEP_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.31e-04 | 126 | 17 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.50e-04 | 132 | 17 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200 | 1.51e-04 | 23 | 17 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_100 | 1.51e-04 | 23 | 17 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 1.65e-04 | 24 | 17 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k1 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | 2.08e-04 | 384 | 17 | 4 | GSM777041_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#3_top-relative-expression-ranked_100 | 2.09e-04 | 27 | 17 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.10e-04 | 148 | 17 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_200 | 2.14e-04 | 149 | 17 | 3 | gudmap_developingLowerUrinaryTract_adult_ureter_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_1000 | 2.16e-04 | 736 | 17 | 5 | gudmap_developingLowerUrinaryTract_adult_ureter_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_200 | 2.18e-04 | 150 | 17 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_500 | 2.18e-04 | 389 | 17 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 2.21e-04 | 390 | 17 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#2_top-relative-expression-ranked_100 | 2.42e-04 | 29 | 17 | 2 | gudmap_developingLowerUrinaryTract_adult_ureter_100_k2 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.45e-04 | 156 | 17 | 3 | ratio_MESO_vs_SC_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 2.60e-04 | 407 | 17 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 2.62e-04 | 408 | 17 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | KRT6C KRT1 KRT3 KRT4 KRT5 KRT6A KRT6B KRT13 KRT14 KRT76 KRT16 | 9.76e-23 | 196 | 17 | 11 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | KRT6C KRT1 KRT3 KRT4 KRT5 KRT6A KRT6B KRT13 KRT14 KRT76 KRT16 | 1.03e-22 | 197 | 17 | 11 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.89e-20 | 197 | 17 | 10 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-17 | 197 | 17 | 9 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-17 | 197 | 17 | 9 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 9.14e-16 | 172 | 17 | 8 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.15e-15 | 177 | 17 | 8 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-15 | 185 | 17 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.97e-15 | 189 | 17 | 8 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.97e-15 | 189 | 17 | 8 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.05e-15 | 190 | 17 | 8 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.05e-15 | 190 | 17 | 8 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.05e-15 | 190 | 17 | 8 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-15 | 191 | 17 | 8 | cd4e2e883c4955fb2d875e41bb6ebc680994dc8c | |
| ToppCell | facs-Trachea-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-15 | 192 | 17 | 8 | c5823c5d4c58a4e9121a4b7d7256481d6d9e9b7f | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 2.64e-15 | 196 | 17 | 8 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-15 | 197 | 17 | 8 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-15 | 197 | 17 | 8 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.75e-15 | 197 | 17 | 8 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-15 | 197 | 17 | 8 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.87e-15 | 198 | 17 | 8 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.87e-15 | 198 | 17 | 8 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | distal-1-Epithelial-Proliferating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-15 | 199 | 17 | 8 | 93450257180d918c310bca7b5defc74390c48091 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.11e-15 | 200 | 17 | 8 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | distal-Epithelial-Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.11e-15 | 200 | 17 | 8 | 5c14f0c09bb8b3daf6d649032e888a7880c52b73 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-15 | 200 | 17 | 8 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.11e-15 | 200 | 17 | 8 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | distal-Epithelial-Proliferating_Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.11e-15 | 200 | 17 | 8 | cc31e8c28d01e6757c5dd7f485db6acf7409a47e | |
| ToppCell | distal-Epithelial-Proliferating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.11e-15 | 200 | 17 | 8 | 25cc494ef831511840d8c02ec1bd086635cc7edd | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.36e-13 | 163 | 17 | 7 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-13 | 168 | 17 | 7 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | facs-Heart-RV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-13 | 172 | 17 | 7 | a26a73c41e5a05c9dd47a99f3320295f684c5e54 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-13 | 173 | 17 | 7 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.16e-13 | 174 | 17 | 7 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-13 | 174 | 17 | 7 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-13 | 175 | 17 | 7 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-13 | 175 | 17 | 7 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-13 | 175 | 17 | 7 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-13 | 181 | 17 | 7 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-13 | 181 | 17 | 7 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-13 | 182 | 17 | 7 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.20e-13 | 184 | 17 | 7 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | facs-Trachea-nan-18m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-13 | 187 | 17 | 7 | 8882a638af7165b2910ba8e932d55475d7bfb003 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-13 | 190 | 17 | 7 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-new-cluster|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-13 | 192 | 17 | 7 | e4fb3f18da7dc6a835023db69a8d99737c39ef86 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-keratinocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-13 | 192 | 17 | 7 | 4530b3028928d089b3a71eb19a4df237f58a50ae | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.49e-13 | 193 | 17 | 7 | 83d2dd823808a2b5ca1a6889eefb541ec042b24c | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-13 | 193 | 17 | 7 | 77bc4353a1e9eae32bc6beb333577ba0294a10fc | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-13 | 193 | 17 | 7 | b9b431c18c81c616069a546cded4753563a1e701 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.66e-13 | 194 | 17 | 7 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | droplet-Tongue|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-13 | 195 | 17 | 7 | e460b09ae354b579ce552acebdaa5877a6e62343 | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-13 | 195 | 17 | 7 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-13 | 197 | 17 | 7 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-13 | 198 | 17 | 7 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.58e-13 | 199 | 17 | 7 | 8be7cb9d8b4f9707efb69c681c40e683fcd810e5 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.78e-13 | 200 | 17 | 7 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 5.78e-13 | 200 | 17 | 7 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.97e-11 | 157 | 17 | 6 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.04e-11 | 158 | 17 | 6 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-11 | 160 | 17 | 6 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-11 | 160 | 17 | 6 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-11 | 160 | 17 | 6 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-11 | 161 | 17 | 6 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-11 | 162 | 17 | 6 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-11 | 162 | 17 | 6 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.56e-11 | 164 | 17 | 6 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-11 | 167 | 17 | 6 | 29d271643f3a1718b53db77b7d093ec94225a824 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-11 | 171 | 17 | 6 | d2a10e94b0490120d1420b944302eb841f902c64 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.30e-11 | 171 | 17 | 6 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 3.54e-11 | 173 | 17 | 6 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-11 | 174 | 17 | 6 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-11 | 174 | 17 | 6 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-11 | 174 | 17 | 6 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.93e-11 | 176 | 17 | 6 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | facs-Trachea-18m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-11 | 177 | 17 | 6 | 68c9a8a82c956cbfdf03b44984c97f978aaaf80f | |
| ToppCell | facs-Trachea-nan-18m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-11 | 177 | 17 | 6 | fc30276903bcb1e95ae76f6cee3d17408158941a | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-11 | 178 | 17 | 6 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-11 | 178 | 17 | 6 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-11 | 181 | 17 | 6 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-11 | 181 | 17 | 6 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-11 | 185 | 17 | 6 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-11 | 187 | 17 | 6 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.67e-11 | 187 | 17 | 6 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-11 | 189 | 17 | 6 | ee15b4fb3a1cfda80bcf210a23f04f242594015e | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-11 | 189 | 17 | 6 | dc6f6fae84347d145bea71b49eaeeb3028e9c4ae | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-11 | 190 | 17 | 6 | 576c45a30a4808b47433bc6c2c41396135556c40 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.44e-11 | 191 | 17 | 6 | b55500eb416f4f339031acad16b2737e5b891d8e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.86e-11 | 193 | 17 | 6 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | facs-Trachea-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-11 | 193 | 17 | 6 | ec49a83b24371579d4ad46aad91c25115aa226f9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-11 | 195 | 17 | 6 | 17c4d3b59cd0d79ce9ae5dde95586f3e923db16f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-11 | 195 | 17 | 6 | f7a4ce7076148389471678bcc5349df8b72b653e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-11 | 195 | 17 | 6 | 66caa5c063184e7d3d653c8f6c289555cb36fa82 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-11 | 195 | 17 | 6 | ed74c113074fb5d3c42f2330b0e6042d32c3611a | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.76e-11 | 197 | 17 | 6 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | control-Epithelial-Squamous|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.00e-11 | 198 | 17 | 6 | 6ba669ac1ed275ae309054941b1457e315766faa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.00e-11 | 198 | 17 | 6 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.00e-11 | 198 | 17 | 6 | 6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-11 | 198 | 17 | 6 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.00e-11 | 198 | 17 | 6 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.00e-11 | 198 | 17 | 6 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| Computational | Keratin. | 9.36e-25 | 26 | 14 | 10 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 9.36e-25 | 26 | 14 | 10 | MODULE_68 | |
| Computational | Genes in the cancer module 153. | 1.22e-17 | 34 | 14 | 8 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.58e-16 | 50 | 14 | 8 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Intermediate filaments and MT. | 9.79e-13 | 68 | 14 | 7 | MODULE_438 | |
| Computational | Genes in the cancer module 297. | 3.18e-12 | 80 | 14 | 7 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 3.18e-12 | 80 | 14 | 7 | MODULE_357 | |
| Computational | Developmental processes. | 4.13e-11 | 333 | 14 | 9 | MODULE_220 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.01e-07 | 50 | 14 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.01e-07 | 50 | 14 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Computational | Intermediate filaments. | 2.08e-06 | 75 | 14 | 4 | MODULE_154 | |
| Computational | Neighborhood of SPRR1B | 3.50e-06 | 24 | 14 | 3 | GNF2_SPRR1B | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.33e-05 | 50 | 14 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes in the cancer module 342. | 1.28e-04 | 213 | 14 | 4 | MODULE_342 | |
| Computational | Thymus genes. | 6.46e-04 | 325 | 14 | 4 | MODULE_44 | |
| Computational | Genes in the cancer module 533. | 1.51e-03 | 45 | 14 | 2 | MODULE_533 | |
| Computational | Trachea genes. | 1.61e-03 | 415 | 14 | 4 | MODULE_6 | |
| Computational | Genes in the cancer module 322. | 2.58e-03 | 59 | 14 | 2 | MODULE_322 | |
| Computational | Immune (humoral) and inflammatory response. | 4.38e-03 | 546 | 14 | 4 | MODULE_84 | |
| Computational | Genes in the cancer module 41. | 4.99e-03 | 566 | 14 | 4 | MODULE_41 | |
| Computational | Genes in the cancer module 157. | 8.41e-03 | 108 | 14 | 2 | MODULE_157 | |
| Drug | teleocidin B | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.23e-36 | 123 | 17 | 16 | CID000072425 |
| Drug | sulfur mustard | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 8.29e-36 | 130 | 17 | 16 | CID000010461 |
| Drug | homocysteine thiolactone | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 9.45e-36 | 131 | 17 | 16 | CID000107712 |
| Drug | al-Badry | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 4.64e-34 | 165 | 17 | 16 | CID000004545 |
| Drug | AC1L9MJT | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT15 KRT16 | 5.96e-30 | 192 | 17 | 15 | CID000448959 |
| Drug | Velcade (bortezomib | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.42e-28 | 374 | 17 | 16 | CID000093860 |
| Drug | 1-2q | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT15 KRT16 | 3.30e-27 | 289 | 17 | 15 | CID000011820 |
| Drug | butyrate | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 3.89e-23 | 767 | 17 | 16 | CID000000264 |
| Drug | adenosine 3',5'-cyclic phosphate | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 5.80e-22 | 907 | 17 | 16 | CID000000274 |
| Drug | olomoucine II | 3.00e-20 | 27 | 17 | 8 | CID005494414 | |
| Drug | phenyl isocyanate | 6.40e-20 | 6 | 17 | 6 | ctd:C025319 | |
| Drug | ethylnylestradiol | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 1.02e-19 | 1251 | 17 | 16 | CID000003285 |
| Drug | phorbol acetate myristate | KRT6C KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT15 KRT16 | 6.10e-19 | 1399 | 17 | 16 | CID000004792 |
| Drug | dithranol | 9.80e-19 | 18 | 17 | 7 | CID000002202 | |
| Drug | CK 6 | 2.56e-17 | 58 | 17 | 8 | CID000447960 | |
| Drug | CK17 | 8.02e-15 | 57 | 17 | 7 | CID000128831 | |
| Drug | Divonex | 3.26e-14 | 69 | 17 | 7 | CID000002522 | |
| Drug | chrysarobin | 1.47e-13 | 37 | 17 | 6 | CID000068111 | |
| Drug | AC1L1GT5 | 3.30e-13 | 95 | 17 | 7 | CID000003829 | |
| Drug | clobestasol propionate | 7.47e-13 | 17 | 17 | 5 | CID000002791 | |
| Drug | NSC34533 | 1.62e-12 | 54 | 17 | 6 | CID000003512 | |
| Drug | Olux | 1.87e-12 | 20 | 17 | 5 | CID000032797 | |
| Drug | cignolin | 2.04e-12 | 56 | 17 | 6 | CID000010187 | |
| Drug | SC-791 | 3.19e-12 | 6 | 17 | 4 | CID010291510 | |
| Drug | betamethasone valerate | 1.18e-11 | 28 | 17 | 5 | CID000016533 | |
| Drug | AC1NQZM2 | 1.43e-11 | 29 | 17 | 5 | CID005282177 | |
| Drug | 1pxm | 1.60e-11 | 78 | 17 | 6 | CID000447959 | |
| Drug | CD367 | 2.85e-11 | 33 | 17 | 5 | CID000119342 | |
| Drug | I5B1 | 5.22e-11 | 37 | 17 | 5 | CID005487705 | |
| Drug | 4-oxoretinoic acid | 1.72e-10 | 115 | 17 | 6 | ctd:C002202 | |
| Drug | bromovanin | 3.15e-10 | 127 | 17 | 6 | ctd:C515564 | |
| Drug | K-11 | 5.03e-10 | 17 | 17 | 4 | CID000469667 | |
| Drug | DMBA | 5.68e-10 | 140 | 17 | 6 | CID000006001 | |
| Drug | benzalkonium | 7.95e-10 | 148 | 17 | 6 | CID000007681 | |
| Drug | 9-cis-acitretin | 1.54e-09 | 71 | 17 | 5 | CID000041317 | |
| Drug | Lh 1 | 1.54e-09 | 22 | 17 | 4 | CID000191841 | |
| Drug | MK-6 | 2.24e-09 | 24 | 17 | 4 | CID005283547 | |
| Drug | 4-oxoretinoic acid | 2.32e-09 | 77 | 17 | 5 | CID006437063 | |
| Drug | AC1L1KPQ | 2.48e-09 | 78 | 17 | 5 | CID000005602 | |
| Drug | 4-hydroxytestosterone | 2.48e-09 | 78 | 17 | 5 | CID000160615 | |
| Drug | CD437 | 5.32e-09 | 203 | 17 | 6 | CID000135411 | |
| Drug | K-13 | 6.61e-09 | 31 | 17 | 4 | CID000469669 | |
| Drug | ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid | 6.91e-09 | 6 | 17 | 3 | ctd:C034814 | |
| Drug | NSC134723 | 6.91e-09 | 6 | 17 | 3 | CID000281830 | |
| Drug | liarozole | 1.72e-08 | 39 | 17 | 4 | CID000060652 | |
| Drug | tazarotene | 1.91e-08 | 40 | 17 | 4 | CID000005381 | |
| Drug | 2,4-diacetylphloroglucinol | 2.83e-08 | 44 | 17 | 4 | CID000016547 | |
| Drug | PD153035 | 2.93e-08 | 127 | 17 | 5 | CID000004705 | |
| Drug | CTFE | 3.40e-08 | 46 | 17 | 4 | CID000006594 | |
| Drug | mant-GTP | 4.79e-08 | 50 | 17 | 4 | CID000128647 | |
| Drug | alitretinoin | 5.56e-08 | 301 | 17 | 6 | ctd:C103303 | |
| Drug | phenyl saligenin phosphate | 7.63e-08 | 56 | 17 | 4 | CID000104885 | |
| Drug | DIMIT | 7.63e-08 | 56 | 17 | 4 | CID000006624 | |
| Drug | triphenyltin | 9.84e-08 | 13 | 17 | 3 | CID005357402 | |
| Drug | Ro 13-6298 | 9.84e-08 | 13 | 17 | 3 | CID006437076 | |
| Drug | Diethylstilbestrol | 1.04e-07 | 1305 | 17 | 9 | ctd:D004054 | |
| Drug | N-nitrosomorpholine | 1.10e-07 | 338 | 17 | 6 | ctd:C002741 | |
| Drug | 3-deoxy-3-fluoro-D-glucose | 1.56e-07 | 15 | 17 | 3 | CID000450201 | |
| Drug | AC1O3H1D | 1.58e-07 | 67 | 17 | 4 | CID006328166 | |
| Drug | bilirubin-phosphate | 1.92e-07 | 16 | 17 | 3 | CID005497144 | |
| Drug | antipsoriatic | 2.00e-07 | 71 | 17 | 4 | CID000005585 | |
| Drug | bromodeoxyuridine | 2.07e-07 | 376 | 17 | 6 | CID000006035 | |
| Drug | JTV-519 | 2.80e-07 | 18 | 17 | 3 | CID000001715 | |
| Drug | K 10 | 3.33e-07 | 19 | 17 | 3 | CID000221089 | |
| Drug | plakin | 3.59e-07 | 82 | 17 | 4 | CID000018752 | |
| Drug | AC1L9LMC | 3.77e-07 | 83 | 17 | 4 | CID000448113 | |
| Drug | AC1NPJ0T | 3.91e-07 | 20 | 17 | 3 | CID005159168 | |
| Drug | N1-acetylspermidine | 3.91e-07 | 20 | 17 | 3 | CID000000496 | |
| Drug | benzyl nicotinate | 5.25e-07 | 2 | 17 | 2 | CID000007191 | |
| Drug | isobutoxy | 5.25e-07 | 2 | 17 | 2 | CID000010557 | |
| Drug | sodium dodecyl sulfate | 5.46e-07 | 91 | 17 | 4 | CID000008778 | |
| Drug | potassiopotassium | 6.22e-07 | 94 | 17 | 4 | CID006432276 | |
| Drug | Bhg-(2-1)fuc | 7.87e-07 | 25 | 17 | 3 | CID005287784 | |
| Drug | Isotretinoin | 9.13e-07 | 799 | 17 | 7 | ctd:D015474 | |
| Drug | Bi-E | 1.00e-06 | 27 | 17 | 3 | CID006914595 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 1.12e-06 | 28 | 17 | 3 | CID011650719 | |
| Drug | bexarotene | 1.21e-06 | 111 | 17 | 4 | CID000082146 | |
| Drug | M50054 | 1.50e-06 | 117 | 17 | 4 | CID002748618 | |
| Drug | 2-Formyl-Protoporphryn Ix | 1.53e-06 | 31 | 17 | 3 | CID011963946 | |
| Drug | AGN 193109 | 1.53e-06 | 31 | 17 | 3 | CID000177238 | |
| Drug | tryptophan ethyl ester | 1.57e-06 | 3 | 17 | 2 | CID000081996 | |
| Drug | N8T | 1.57e-06 | 3 | 17 | 2 | CID006540271 | |
| Drug | 4,4'-thiodiphenol | 1.69e-06 | 32 | 17 | 3 | CID000017570 | |
| Drug | Mustard Gas | 2.14e-06 | 1341 | 17 | 8 | ctd:D009151 | |
| Drug | mantATP | 2.23e-06 | 35 | 17 | 3 | CID000123756 | |
| Drug | tsuwabukinonol | 2.64e-06 | 37 | 17 | 3 | CID006440419 | |
| Drug | CaLam | 3.11e-06 | 39 | 17 | 3 | CID004126474 | |
| Drug | sandostatinLAR | 3.33e-06 | 143 | 17 | 4 | ctd:C541923 | |
| Drug | glycylglycylglycine | 3.36e-06 | 40 | 17 | 3 | CID000011161 | |
| Drug | A805480 | 4.49e-06 | 44 | 17 | 3 | CID000620368 | |
| Drug | D-glucamine | 4.81e-06 | 45 | 17 | 3 | CID000027282 | |
| Drug | ClOClO | 7.86e-06 | 6 | 17 | 2 | CID000517862 | |
| Drug | CD-III | 7.91e-06 | 53 | 17 | 3 | CID000066693 | |
| Drug | AC1N9J6O | 8.67e-06 | 182 | 17 | 4 | CID004411483 | |
| Drug | R-Te | 9.87e-06 | 57 | 17 | 3 | CID000068913 | |
| Drug | 1q6k | 1.04e-05 | 58 | 17 | 3 | CID000448022 | |
| Drug | ClOO | 1.10e-05 | 7 | 17 | 2 | CID005460593 | |
| Drug | 3-buten-1-ol | 1.10e-05 | 7 | 17 | 2 | CID000069389 | |
| Drug | Calcein AM | 1.27e-05 | 62 | 17 | 3 | CID000390986 | |
| Drug | AC1LAHKK | 1.40e-05 | 64 | 17 | 3 | CID000468577 | |
| Disease | Keratoderma, Palmoplantar | 1.45e-13 | 16 | 17 | 5 | C4551675 | |
| Disease | Pachyonychia Congenita | 3.77e-13 | 5 | 17 | 4 | C0265334 | |
| Disease | Keratoderma, Palmoplantar, Epidermolytic | 1.59e-10 | 3 | 17 | 3 | C1721006 | |
| Disease | Epidermolytic palmoplantar keratoderma Vorner type | 1.59e-10 | 3 | 17 | 3 | C2931735 | |
| Disease | Epidermolytic palmoplantar keratoderma of Vorner | 1.59e-10 | 3 | 17 | 3 | C0343110 | |
| Disease | Pachyonychia congenita syndrome | 6.35e-10 | 4 | 17 | 3 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 6.35e-10 | 4 | 17 | 3 | C1721007 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 6.35e-10 | 4 | 17 | 3 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 6.35e-10 | 4 | 17 | 3 | DOID:0050449 (is_implicated_in) | |
| Disease | Epidermolysis bullosa simplex with mottled pigmentation | 3.12e-07 | 2 | 17 | 2 | C0432316 | |
| Disease | Leukokeratosis, Hereditary Mucosal | 3.12e-07 | 2 | 17 | 2 | C1721005 | |
| Disease | white sponge nevus (implicated_via_orthology) | 3.12e-07 | 2 | 17 | 2 | DOID:0050448 (implicated_via_orthology) | |
| Disease | Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis | 3.12e-07 | 2 | 17 | 2 | C1843463 | |
| Disease | Epidermolytic ichthyosis | 3.12e-07 | 2 | 17 | 2 | cv:C0079153 | |
| Disease | Erythrokeratoderma, Reticular | 3.12e-07 | 2 | 17 | 2 | C1836681 | |
| Disease | Annular epidermolytic ichthyosis | 3.12e-07 | 2 | 17 | 2 | cv:C1843463 | |
| Disease | epidermolysis bullosa simplex Dowling-Meara type (implicated_via_orthology) | 3.12e-07 | 2 | 17 | 2 | DOID:0060735 (implicated_via_orthology) | |
| Disease | EPIDERMOLYSIS BULLOSA SIMPLEX 1A, GENERALIZED SEVERE | 3.12e-07 | 2 | 17 | 2 | 131760 | |
| Disease | epidermolytic hyperkeratosis (is_implicated_in) | 3.12e-07 | 2 | 17 | 2 | DOID:4603 (is_implicated_in) | |
| Disease | cinnamaldehyde measurement | 3.12e-07 | 2 | 17 | 2 | EFO_0021839 | |
| Disease | Palmoplantar keratoderma, epidermolytic | 3.12e-07 | 2 | 17 | 2 | cv:C1721006 | |
| Disease | Congenital reticular ichthyosiform erythroderma | 3.12e-07 | 2 | 17 | 2 | C3665704 | |
| Disease | EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1 | 3.12e-07 | 2 | 17 | 2 | C3715082 | |
| Disease | Keratosis of Greither | 3.12e-07 | 2 | 17 | 2 | C2936837 | |
| Disease | Epidermolysis bullosa simplex 1A, generalized severe | 3.12e-07 | 2 | 17 | 2 | cv:C0079295 | |
| Disease | Epidermolysis bullosa simplex | 3.12e-07 | 2 | 17 | 2 | cv:C0079298 | |
| Disease | sphingomyelin measurement | 4.04e-07 | 278 | 17 | 5 | EFO_0010118 | |
| Disease | Squamous cell carcinoma | 6.78e-07 | 124 | 17 | 4 | C0007137 | |
| Disease | Epidermolysis Bullosa Herpetiformis Dowling-Meara | 9.37e-07 | 3 | 17 | 2 | C0079295 | |
| Disease | Epidermolysis Bullosa Simplex Kobner | 9.37e-07 | 3 | 17 | 2 | C0079299 | |
| Disease | Weber-Cockayne Syndrome | 9.37e-07 | 3 | 17 | 2 | C0080333 | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 9.37e-07 | 3 | 17 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder) | 9.37e-07 | 3 | 17 | 2 | C1832926 | |
| Disease | Epidermolysis Bullosa | 1.87e-06 | 4 | 17 | 2 | C0014527 | |
| Disease | Epidermolysis Bullosa Simplex | 3.12e-06 | 5 | 17 | 2 | C0079298 | |
| Disease | Hyperkeratosis, Epidermolytic | 3.12e-06 | 5 | 17 | 2 | C0079153 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 6.55e-06 | 7 | 17 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Contact hypersensitivity | 8.86e-06 | 71 | 17 | 3 | C0162351 | |
| Disease | Contact Dermatitis | 8.86e-06 | 71 | 17 | 3 | C0011616 | |
| Disease | Neoplastic Cell Transformation | 6.63e-05 | 139 | 17 | 3 | C0007621 | |
| Disease | cutaneous squamous cell carcinoma | 1.63e-04 | 33 | 17 | 2 | EFO_1001927 | |
| Disease | Malignant neoplasm of salivary gland | 3.05e-04 | 45 | 17 | 2 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 3.33e-04 | 47 | 17 | 2 | C0036095 | |
| Disease | Skin Neoplasms | 5.24e-04 | 59 | 17 | 2 | C0037286 | |
| Disease | Malignant neoplasm of skin | 5.24e-04 | 59 | 17 | 2 | C0007114 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGFGGSYGGGFGGGR | 96 | Q01546 | |
| FGGAGGFGGAGGFGG | 116 | Q01546 | |
| GFGGAGGFGGPGVFG | 121 | Q01546 | |
| GGFGGPGVFGGPGSF | 126 | Q01546 | |
| YGFGGAGSGFGFGGG | 91 | P48668 | |
| GFGGGAGIGFGLGGG | 101 | P48668 | |
| IFGGGSFGGGSFGGG | 101 | P13645 | |
| SFGGGSFGGGGFGGG | 111 | P13645 | |
| GGFGGGYGSGFGGFG | 121 | P35527 | |
| GYGSGFGGFGGFGGG | 126 | P35527 | |
| FGGFGGFGGGAGGGD | 131 | P35527 | |
| YGFGGAGSGFGFGGG | 91 | P02538 | |
| GFGGGAGIGFGLGGG | 101 | P02538 | |
| GGGGGGGYAPYGRPG | 161 | Q14526 | |
| GSGFGGGYGGGLGAG | 81 | P02533 | |
| GGYGGGLGAGLGGGF | 86 | P02533 | |
| SGFSGGGFGGGGFGG | 106 | P35908 | |
| GGFGGGGFGGGRFGG | 111 | P35908 | |
| GGFGGGRFGGFGGPG | 116 | P35908 | |
| GRFGGFGGPGGVGGL | 121 | P35908 | |
| GFGSGYGGGFGGGFG | 96 | P12035 | |
| YGGGFGGGFGGGRGM | 101 | P12035 | |
| GGAGGFGGAGGFGGP | 126 | P12035 | |
| FGGAGGFGGPGGFGG | 131 | P12035 | |
| GFGGPGGFGGSGGFG | 136 | P12035 | |
| GYGGGMGGGLGGGFS | 541 | P12035 | |
| AGGGYGFGGGAGSGF | 91 | P13647 | |
| GFGGGAGSGFGFGGG | 96 | P13647 | |
| AGSGFGFGGGAGGGF | 101 | P13647 | |
| AGGGFGLGGGAGFGG | 111 | P13647 | |
| GLGGGAGFGGGFGGP | 116 | P13647 | |
| GAGGFGTGGFGGGFG | 76 | P19013 | |
| GAGSGFGGGYGGGLG | 56 | P13646 | |
| GLGGGFGGGFAGGFV | 76 | P13646 | |
| RGSGFGGGYGGGGFG | 86 | P04264 | |
| YGFGGAGSGFGFGGG | 91 | P04259 | |
| GFGGGAGIGFGLGGG | 101 | P04259 | |
| GFGGGYGGGLGAGFG | 81 | P08779 | |
| GAGFGGGLGAGFGGG | 91 | P08779 | |
| VFGGGFGGGVGGGFG | 76 | P19012 | |
| GFGGGGFGGAGFGTS | 106 | Q7Z794 |